Zydus Lifesciences Ltd share price logo

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE

BSE: 532321

Large Cap

Healthcare Sector

Pharma Sector

₹1150.80

-8.20

(-0.71%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Zydus Lifesciences Stock Performance

as on July 10, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,145.00
    ₹1,164.90
    downward going graph

    0.50%

    Downside

    1.23%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹835.50
    ₹1,181.50
    downward going graph

    27.40%

    Downside

    2.67%

    Upside

    downward going graph

Zydus Lifesciences share price movements today

Previous Close
₹1,159.00
Open
₹1,161.60
Volume
8.24L
Upper Circuit
₹1,274.90
Lower Circuit
₹1,043.10
Day's Low - High
₹1,145.00 - ₹1,164.90
52 Week Low - High
₹835.50 - ₹1,181.50

Zydus Lifesciences Historical Returns

1 Month Return
+ 4.06 %
3 Month Return
+ 24.76 %
1 Year Return
+ 17.48 %
3 Year Return
+ 96.77 %
5 Year Return
+ 78.39 %

Zydus Lifesciences Fundamentals

as on July 10, 2026 at 4:01 pm IST

Market Cap

₹1,15,610.69 Cr

Return on Equity (ROE)

31.29

PE Ratio (TTM)

22.91

Return on capital employed (ROCE)

30.47

Industry PE ratio

50.84

Beta (LTM)

0.76

P/B Ratio

4.2

Dividend Yield

1.24

PEG Ratio

4.48

Quarterly Earnings Growth YOY

7.41

EPS (TTM)

45.87

Book Value

238.1

Zydus Lifesciences Stock Valuation

as on July 10, 2026 at 4:01 pm IST

Zydus Lifesciences in the last 5 years

  • Overview

  • Trends

Lowest (7.34x)

March 7, 2022

Today (22.91x)

July 6, 2026

Industry (50.84x)

July 6, 2026

Highest (34.62x)

March 26, 2024

LowHigh

Today’s Price to Earnings Ratio: 22.91x

Zydus Lifesciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Zydus Lifesciences with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Zydus Lifesciences Ltd image
Zydus Lifesciences Ltd
BUY1,15,610.6915.68%0.614,61423,241
Sanofi India Ltd image
Sanofi India Ltd
BUY7,728.87-11.45%0.004132,013
Aurobindo Pharma Ltd image
Aurobindo Pharma Ltd
BUY92,196.4513.27%0.603,48331,723
Abbott India Ltd image
Abbott India Ltd
BUY56,886.2511.37%0.001,4146,445
Glaxosmithkline Pharmaceuticals Ltd image
Glaxosmithkline Pharmaceuticals Ltd
BUY41,341.8512.6%0.561,0353,821
See all

Market expectation of Zydus Lifesciences Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

50.00%

Buy

33.33%

Hold

16.67%

Sell

Zydus Lifesciences Stock’s Investor Sentiment and Interest

Investment in Zydus Lifesciences Ltd Shares on INDmoney has dropped by -49.25% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-49.25% versus previous 30 day period

Search interest for Zydus Lifesciences Ltd Stock has decreased by -27% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-27% versus previous 30 day period

Zydus Lifesciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
4,258.6
4,343.7
5,366.4
6,046.5
5,113.6
5,123.5
6,290.2
6,467
6,037.9
6,780.4
7,434.4
Other Income
54
59.5
159.6
63.2
68.5
57.5
80.6
154.9
109
111.4
134.2
Total Income
4,422.8
4,564.7
5,693.4
6,270.7
5,305.5
5,326.6
6,608.5
6,728.6
6,232.2
6,975.9
7,721.2
Expenses
3,223.7
3,402.8
3,903.3
4,123.5
3,775.6
3,881.8
4,622
4,485.2
4,141.6
5,133
5,430.1
Operating Profit
1,034.9
940.9
1,463.1
1,923
1,338
1,241.7
1,668.2
1,981.8
1,896.3
1,647.4
2,004.3
Operating Profit Margin %
24.3%
21.66%
27.26%
31.8%
26.17%
24.24%
26.52%
30.64%
31.41%
24.3%
26.96%
Profit Before Interest, Tax and Depreciation
1,199.1
1,161.9
1,790.1
2,147.2
1,529.9
1,444.8
1,986.5
2,243.4
2,090.6
1,842.9
2,291.1
Interest
8.7
19.8
34.6
32.2
25.1
32
76.6
84.7
101.3
129.9
123
Depreciation
184.2
194.8
205.3
215.3
233.6
229
237.9
238.1
301.9
359.6
508.4
Profit Before Tax
1,006.2
947.3
1,550.2
1,899.7
1,271.2
1,183.8
1,672
1,920.6
1,687.4
1,353.4
1,659.7
Tax Paid
226.4
213.8
321.2
436.1
373.1
179.5
423.2
434
454
388.3
318.4
Profit After Tax
779.8
733.5
1,229
1,463.6
898.1
1,004.3
1,248.8
1,486.6
1,233.4
965.1
1,341.3
Total Net profit including share of profit / Loss from associate company
803.2
789.9
1,246.1
1,482.5
920.2
1,026.2
1,243.7
1,521
1,238.6
1,022.9
1,341
EPS
7.91
7.8
11.69
14.11
9.06
10.17
11.64
14.58
12.51
10.36
12.65
Actual EPS
7.91
7.8
11.69
14.11
9.06
10.17
11.64
14.58
12.51
10.36
12.65
Adjusted EPS
7.91
7.8
11.69
14.11
9.06
10.17
11.64
14.58
12.51
10.36
12.65
Diluted EPS
7.91
7.8
11.69
14.11
9.06
10.17
11.64
14.58
12.51
10.36
12.65

Zydus Lifesciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
11,581.3
12,748.4
13,812.1
14,125
14,827.6
16,877.8
19,021.5
22,573.8
26,719.7
Other Income
113.2
201.1
113.9
45.6
2,583.1
186.6
307.1
269.5
509.5
Total Income
12,018.1
13,366.7
14,367
14,449.1
17,693
17,424
19,854.5
23,511
27,657.9
Expenses
9,076.2
10,192.5
11,833.3
11,289.5
11,769.2
13,986.3
14,177.3
16,402.6
19,189.9
Operating Profit
2,505.1
2,555.9
1,978.8
2,835.5
3,058.4
2,891.5
4,844.2
6,171.2
7,529.8
Operating Profit Margin %
21.63%
20.05%
14.33%
20.07%
20.63%
17.13%
25.47%
27.34%
28.18%
Profit Before Interest, Tax and Depreciation
2,941.9
3,174.2
2,533.7
3,159.6
5,923.8
3,437.7
5,677.2
7,108.4
8,468
Interest
91.1
193.5
341.8
158.8
127
129.9
81.2
165.9
438.9
Depreciation
538.8
598.6
696.5
669.6
713
722.7
764.1
915.8
1,408
Profit Before Tax
2,312
2,382.1
1,495.4
2,331.2
5,083.8
2,585.1
4,831.9
6,026.7
6,621.1
Tax Paid
564.4
530.3
319.8
193.6
511.7
587.8
977.5
1,411.9
1,594.7
Profit After Tax
1,747.6
1,851.8
1,175.6
2,137.6
4,572.1
1,997.3
3,854.4
4,614.8
5,026.4
Total Net profit including share of profit / Loss from associate company
1,810.4
1,898.7
1,204.4
2,185
4,618.3
2,091.9
3,972.8
4,672.6
5,123.5
EPS
17.35
18.06
11.49
20.85
43.84
19.3
38.14
44.97
50.09
Actual EPS
17.35
18.06
11.49
20.85
43.84
19.3
38.14
44.97
50.09
Adjusted EPS
17.35
18.06
11.49
20.85
43.84
19.3
38.14
44.97
50.09
Diluted EPS
17.35
18.06
11.49
20.85
43.84
19.3
38.14
44.97
50.09

Zydus Lifesciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
1,893.5
1,311.7
919.3
1,281.9
2,505.4
3,293
2,104.1
2,688.8
3,227.9
6,776.7
Cash Flow from Investing Activities
-859.6
-2,871.9
-973.7
-3,977.4
-1,012.3
-834.6
1,137.1
1,177.8
-1,492.3
-8,377.1
Cash Flow from Financing Activities
-934.8
2,315.8
51.5
1,884.6
-1,094.2
-2,548.9
-868.3
-4,400.4
-1,810.4
2,014.2
Net Cash Flow
99.1
755.6
-2.9
-810.9
398.9
-90.5
2,372.9
-533.8
-74.8
413.8

Zydus Lifesciences Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
74.98%
74.98%
74.98%
74.98%
74.98%
74.98%
74.99%
74.99%
74.99%
75%
75%
75.01%
DII
13.09%
12.79%
12.63%
12.64%
10.65%
10.65%
11.01%
11.13%
10.86%
11.09%
11.2%
11.19%
FII
0%
0%
5.72%
5.59%
7.52%
7.53%
7.32%
7.13%
7.34%
7.06%
6.95%
6.89%
Public
7.07%
6.99%
6.66%
6.8%
6.85%
6.84%
6.68%
6.74%
6.8%
6.85%
6.86%
6.9%
Total Outstanding Shares
1,01,22,04,139
1,01,22,04,139
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
99,75,03,832
Total Shareholders
2,97,953
3,06,495
2,94,324
3,36,309
3,70,863
3,65,356
3,71,619
3,86,127
3,96,105
4,03,266
4,18,314
4,03,889

Mutual Funds that own Zydus Lifesciences Stock

Check out the Mutual Funds with significant holdings in Zydus Lifesciences.

Zydus Lifesciences Corporate Actions

View detailed summary of the earnings and dividend history of Zydus Lifesciences.

  • Zydus Lifesciences Ltd Earnings Results

    Zydus Lifesciences Ltd’s net profit jumped 8.68% since last year same period to ₹1,272.50Cr in the Q4 2025-2026. On a quarterly growth basis, Zydus Lifesciences Ltd has generated 22.11% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Zydus Lifesciences Ltd Dividends May,2026

    In the quarter ending March 2026, Zydus Lifesciences Ltd has declared dividend of ₹1.00 per share on 19 May 2026 - translating a dividend yield of 1.04%.

    Read More about Dividends

Indices Featuring Zydus Lifesciences Stock

Check stock indices that include Zydus Lifesciences.

Nifty100 Quality

₹5,493.65

41.35 (▲0.76%)

BSE Healthcare

₹49,941.13

142.37 (▲0.29%)

Nifty 500

₹23,348.40

267.25 (▲1.16%)

NIFTY PHARMA

₹25,674.10

17.85 (▲0.07%)

Nifty Healthcare

₹16,337.80

30.55 (▲0.19%)

Nifty Next 50

₹72,391.80

905.95 (▲1.27%)

S&P BSE 400 MidSmallCap

₹12,718.47

167.45 (▲1.33%)

S&P BSE 150 MidCap

₹17,001.88

235.35 (▲1.40%)

S&P BSE Dividend Stability

₹1,025.54

6.87 (▲0.67%)

S&P BSE 250 LargeMidCap

₹10,794.90

123.58 (▲1.16%)

Nifty 200

₹14,009.25

156.70 (▲1.13%)

Nifty100 Eq Weig

₹34,601.40

400.50 (▲1.17%)

NIFTY 100

₹25,255.10

265.85 (▲1.06%)

Nifty LargeMidcap 250

₹16,730.55

200.35 (▲1.21%)

BSE 500

₹36,506.10

419.55 (▲1.16%)

BSE 200

₹11,336.50

128.19 (▲1.14%)

Insights on Zydus Lifesciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 1.04K Cr → 1.27K Cr (in ₹), with an average increase of 18.1% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 4.88% to 4.92% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 6.23K Cr → 7.72K Cr (in ₹), with an average increase of 10.2% per quarter

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 75.00% to 75.01% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, ZYDUSLIFE stock has moved up by 26.6%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 6.86% to 6.90% in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 46.7% return, outperforming this stock by 27.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 156.2% return, outperforming this stock by 56.9%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 6.95% to 6.89% in Jun 2026 quarter

Zydus Lifesciences Stock Futures & Options Contracts

View the latest movement in Zydus Lifesciences Futures & Options, including strike prices, expiry dates, and percentage changes.

Zydus Lifesciences Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
ZYDUSLIFE 28 Jul ₹1160 Call
July 28, 2026
₹1160
₹21.3
-3.8
-15.14%
ZYDUSLIFE 28 Jul ₹1200 Call
July 28, 2026
₹1200
₹8.8
-1.6
-15.38%
ZYDUSLIFE 28 Jul ₹1150 Call
July 28, 2026
₹1150
₹26
-4.4
-14.47%
ZYDUSLIFE 28 Jul ₹1170 Call
July 28, 2026
₹1170
₹17.3
-3.25
-15.82%

Zydus Lifesciences Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
ZYDUSLIFE 28 Jul Fut
July 28, 2026
-
₹1155
-6.04
-0.52%
ZYDUSLIFE 25 Aug Fut
August 25, 2026
-
₹1159.9
-7.35
-0.63%
ZYDUSLIFE 29 Sep Fut
September 29, 2026
-
₹1167
-6.22
-0.53%

About Zydus Lifesciences Ltd

Zydus Lifesciences Ltd is a leading pharmaceutical company headquartered in Ahmedabad, India. Incorporated in 1995, the company operates in a number of lines of business, including active pharmaceutical ingredients, formulations, biotechnology, and nutraceuticals.

The company has a strong presence in the global market and is known for its high-quality pharmaceutical products. It manufactures a wide range of generic and specialty drugs, including cardiovascular, anti-infective, anti-diabetic, and oncology medicines. Zydus also produces over-the-counter products and nutritional supplements. Some of its top products include Zetia, Atorvastatin, and Metformin.

Zydus Lifesciences Ltd is also known for its popular brands, such as Cadila, Nutralite, and Zydus Wellness. The company has a strong presence in the Indian market, with its products being sold in more than 20,000 stores across the country. It also exports its products to over 100 countries worldwide.

Revenue: ₹7,434.40Cr as on March 2026 (Q4 FY26)
Net Profit: ₹1,341.30Cr as on March 2026 (Q4 FY26)
Listing date: 18 Apr, 2000
Chairperson Name: Pankaj R Patel
OrganisationZydus Lifesciences Ltd
HeadquartersAhmedabad
IndustryPharmaceuticals
CEOPankaj R Patel
E-voting on sharesClick here to vote

FAQs

What is Zydus Lifesciences share price today?

Zydus Lifesciences share price today stands at ₹1150.8 as on at the close of the market. Zydus Lifesciences share today touched a day high of ₹1164.9 and a low of ₹1145.

What is the 52 week high and 52 week low range for Zydus Lifesciences share?

Zydus Lifesciences touched a 52 week high of ₹1181.5 and a 52 week low of ₹835.5. Zydus Lifesciences share price today i.e. is closed at ₹1150.8, which is -2.60% down from its 52 week high and 37.74% up from its 52 week low.

What is Zydus Lifesciences's market capitalisation today?

Zydus Lifesciences market capitalisation is ₹1,15,610.69 Cr as on .

How to buy Zydus Lifesciences shares?

To buy Zydus Lifesciences shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for ZYDUSLIFE or Zydus Lifesciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Zydus Lifesciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Zydus Lifesciences trading volume today?

Zydus Lifesciences trading volume is 8.24L as on . This means that 8.24L shares of Zydus Lifesciences were bought and sold on the stock market during today's trading session.